We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 163 results
  1. PRMT4 drives post-ischemic angiogenesis via YB1/VEGF signaling

    Abstract

    Angiogenesis is an integral process in many ischemic disorders, and vascular endothelial growth factor (VEGF) plays an important role in it....

    Shu Yan, Ji Hu, ... Zhaohui Wang in Journal of Molecular Medicine
    Article 06 April 2021
  2. BRD7 suppresses invasion and metastasis in breast cancer by negatively regulating YB1-induced epithelial-mesenchymal transition

    Background

    BRD7 is a tumor suppressor known to inhibit cell proliferation and cell cycle progression and initiate apoptosis in breast cancer. However,...

    Weihong Niu, Yanwei Luo, ... Ming Zhou in Journal of Experimental & Clinical Cancer Research
    Article Open access 07 February 2020
  3. rSjp40 inhibits activated hepatic stellate cells by promoting nuclear translocation of YB1 and inducing BMP-7/Smad1/5/8 pathway

    Background

    Activation of hepatic stellate cells is the dominant pathogenic event during the process of liver fibrosis. Bone morphogenic protein...

    Liuting Chen, Qi Zhou, ... Yinong Duan in Parasites & Vectors
    Article Open access 31 May 2019
  4. The WAVE3/β-catenin oncogenic signaling regulates chemoresistance in triple negative breast cancer

    Background

    Metastatic breast cancer is responsible for the death of the majority of breast cancer patients. In fact, metastatic BC is the 2nd leading...

    Wei Wang, Priyanka S. Rana, ... Khalid Sossey-Alaoui in Breast Cancer Research
    Article Open access 22 March 2023
  5. Combination of RSK inhibitor LJH-685 and FLT3 inhibitor FF-10101 promoted apoptosis and proliferation inhibition of AML cell lines

    Purpose

    FLT3 mutations occurred in approximately one third of patients with acute myeloid leukemia (AML). FLT3-ITD mutations caused the constitutive...

    Sen Zhang, Jun Liu, ... Qing-Yun Wu in Cellular Oncology
    Article 29 August 2022
  6. Role of the long non-coding RNAs in regulation of Gemcitabine response in tumor cells

    Chemotherapy is widely used as one of the first line therapeutic methods in cancer patients. However, chemotherapeutic resistance is one of the most...

    Amirhosein Maharati, Yalda Samsami, ... Meysam Moghbeli in Cancer Cell International
    Article Open access 14 August 2023
  7. ROS Modulatory Role of HDAC Inhibitors in Cancer Cells

    Histone deacetylase (HDAC) inhibitors represent a novel class of therapeutic agents for cancer treatment. These enzymes play a pivotal regulatory...
    Janaki Ramaiah Mekala, PrasannaSrinivasan Ramalingam, ... Vijay Kumar Kutala in Handbook of Oxidative Stress in Cancer: Therapeutic Aspects
    Reference work entry 2022
  8. ROS Modulatory Role of HDAC Inhibitors in Cancer Cells

    Histone deacetylase (HDAC) inhibitors represent a novel class of therapeutic agents for cancer treatment. These enzymes play a pivotal regulatory...
    Janaki Ramaiah Mekala, PrasannaSrinivasan Ramalingam, ... Vijay Kumar Kutala in Handbook of Oxidative Stress in Cancer: Therapeutic Aspects
    Living reference work entry 2022
  9. Discovery of a novel ALK/ROS1/FAK inhibitor, APG-2449, in preclinical non-small cell lung cancer and ovarian cancer models

    Background

    Tyrosine kinase inhibitors (TKIs) are mainstays of cancer treatment. However, their clinical benefits are often constrained by acquired...

    Douglas D. Fang, Ran Tao, ... Yifan Zhai in BMC Cancer
    Article Open access 11 July 2022
  10. Ceritinib is a novel triple negative breast cancer therapeutic agent

    Background

    Triple-negative breast cancers (TNBCs) are clinically aggressive subtypes of breast cancer. TNBC is difficult to treat with targeted agents...

    Shengli Dong, Hassan Yousefi, ... Suresh K. Alahari in Molecular Cancer
    Article Open access 29 June 2022
  11. The role of the ZEB1–neuroinflammation axis in CNS disorders

    Zinc finger E-box binding homeobox 1 (ZEB1) is a master modulator of the epithelial–mesenchymal transition (EMT), a process whereby epithelial cells...

    Elham Poonaki, Ulf Dietrich Kahlert, ... Ali Gorji in Journal of Neuroinflammation
    Article Open access 19 November 2022
  12. LncRNA HCP5 Facilitates the Progression of Ovarian Cancer by Interacting with the PTBP1 Protein

    Ovarian cancer (OC) is a major gynecological malignancy with an annually increasing morbidity that poses a significant threat to the health of women...

    Jian Shou, Chuanling Zhang, ... **uJun Wei in Biochemical Genetics
    Article Open access 10 December 2023
  13. Leave no stone unturned: individually adapted xerotolerant Thaumarchaeota sheltered below the boulders of the Atacama Desert hyperarid core

    Background

    The hyperarid core of the Atacama Desert is an extremely harsh environment thought to be colonized by only a few heterotrophic bacterial...

    Yunha Hwang, Dirk Schulze-Makuch, ... Alexander J. Probst in Microbiome
    Article Open access 26 November 2021
  14. RNA-binding proteins in ovarian cancer: a novel avenue of their roles in diagnosis and treatment

    Ovarian cancer (OC), an important cause of cancer-related death in women worldwide, is one of the most malignant cancers and is characterized by a...

    Jiangchun Wu, Yong Wu, ... **aohua Wu in Journal of Translational Medicine
    Article Open access 21 January 2022
  15. MNX1-AS1, a c-Myc induced lncRNA, promotes the Warburg effect by regulating PKM2 nuclear translocation

    Background

    Altered glycolysis is the most fundamental metabolic change associated with the Warburg effect. Some glycolytic enzymes such as PKM2, the...

    Yang Wu, Yichun Wang, ... Lianxin Liu in Journal of Experimental & Clinical Cancer Research
    Article Open access 07 December 2022
  16. Cellular localization of nucleolin determines the prognosis in cancers: a meta-analysis

    Nucleolin (NCL) is a multifunctional protein expressed in the nucleus, cytoplasm, and cell membrane. Overexpression of NCL has a controversial role...

    Supaporn Yangngam, Jaturawitt Prasopsiri, ... Chanitra Thuwajit in Journal of Molecular Medicine
    Article Open access 21 July 2022
  17. Y-Box-Binding Protein-1

    Various reports have proved that Y-box-binding protein-1 (YB-1) is a protein with multiple roles including transcription/translation regulation of...
    Vinoth Prasanna Gunasekaran, Sudarshan Naidu, Kumari Nishi in Handbook of Oxidative Stress in Cancer: Therapeutic Aspects
    Reference work entry 2022
  18. Y-Box-Binding Protein-1

    Various reports have proved that Y-box-binding protein-1 (YB-1) is a protein with multiple roles including transcription/translation regulation of...
    Vinoth Prasanna Gunasekaran, Sudarshan Naidu, Kumari Nishi in Handbook of Oxidative Stress in Cancer: Therapeutic Aspects
    Living reference work entry 2022
  19. p53-regulated lncRNAs in cancers: from proliferation and metastasis to therapy

    Long non-coding RNAs (lncRNAs) have been identified as master gene regulators through various mechanisms such as transcription, translation, protein...

    Kaixin Yang, Yinan **ao, ... Lei Shi in Cancer Gene Therapy
    Article 07 September 2023
Did you find what you were looking for? Share feedback.